ESC Premium Access

Impact of AF type on the outcome of atrial fibrillation ablation: insights from the CABANA trial

Congress Presentation

About the speaker

Assistant Professor Kristi Monahan

Mayo Clinic, Rochester (United States of America)
0 follower

3 more presentations in this session

Direct oral anticoagulant rivaroxaban in very old and frail patients: A one-year prospective follow-up of a large-scale cohort (SAFIR-AC)

Speaker: Professor O. Hanon (Paris, FR)


Blood pressure and white matter lesions in patients with atrial fibrillation

Speaker: Professor D. Conen (Hamilton, CA)


Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)


Access the full session

Atrial fibrillation: from drugs to ablation

Speakers: Assistant Professor K. Monahan, Professor O. Hanon, Professor D. Conen, Professor L. Fauchier

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb